2016 International Congress Archives - Page 29 of 207

12:00pm-1:30pm: Is physiotherapy an effective for treatment of Parkinson’s disease?!

R. Agzamov, S. Tursunov, G. Rakhimbaeva, F. Yunusov, D. Lutfullaeva, J. Olimov, A. Kalendarev, K. Abdukhalimova, R. Mirzaev (Tashkent, Uzbekistan)

Other · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: KINECT 3: A randomized, double-blind, placebo-controlled phase 3 trial of valbenazine (NBI-98854) for tardive dyskinesia

S.A. Factor, R.A. Hauser, S. Siegert, G.S. Liang, C.F. O'Brien (Atlanta, GA, USA)

Parkinson's Disease: Clinical Trials II and Non-PD Clinical Trials

12:00pm-1:30pm: Levodopa-carbidopa intestinal gel in routine care of advanced Parkinson’s disease patients: Final long-term efficacy results on motor complications from the GLORIA registry

W. Poewe, T. Kimber, B. Bermans, P. Odin, A. Antonini, O. Bajenaru, K. Onuk, A. Yegin, L. Bergmann, K.R. Chaudhuri (Innsbruck, Austria)

Parkinson's disease: Clinical trials, pharmacology and treatment · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Levodopa-carbidopa intestinal gel in routine care of advanced Parkinson’s disease patients: Final long-term non-motor, quality of life and safety results from the GLORIA registry

K.R. Chaudhuri, Z. Pirtosek, B. Pickut, W. Poewe, F. Valldeoriola, L. Defebvre, R. Jech, P. Odin, C. Winkler, J. Szasz, K. Onuk, A. Yegin, L. Bergmann, A. Antonini (London, United Kingdom)

Parkinson's disease: Clinical trials, pharmacology and treatment · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Levodopa-carbidopa intestinal gel via PEG-J for advanced Parkinson’s disease- A single centre experience

E. Pekkonen, J. Lyytinen, O. Lindström, L. Kylänpää, M. Udd (Helsinki, Finland)

Pharmacology

12:00pm-1:30pm: Levodopa-entacapone-carbidopa intestinal gel in Parkinson’s disease – A randomized, crossover infusion study

M. Senek, D. Nyholm (Uppsala, Sweden)

Pharmacology

12:00pm-1:30pm: Levodopa, placebo and rotigotine change biomarker levels for oxidative stress

S. Muhlack, M. Kinkel, L. Herrmann, L. Tönges, T. Müller (Bochum, Germany)

Parkinson's Disease: Clinical Trials II and Non-PD Clinical Trials

12:00pm-1:30pm: Levodopa/carbidopa intestinal gel treatment in advanced Parkinson’s disease: A long-term observational study

P. Havránková, J. Klempír, M. Fialová, A. Rezková, J. Petrtýl, V. Capek, E. Ruzicka, J. Roth, R. Jech (Praha, Czech Republic)

Pharmacology

12:00pm-1:30pm: Levodopa/carbidopa intestinal gel, neuropathy, and B-vitamins – Is there an association?

S. Löns, E. Chorbadgieva, A. Kleimann, D. Dressler, C. Schrader (Hannover, Germany)

Parkinson's disease: Clinical trials, pharmacology and treatment · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Localization of basal ganglia and thalamic damage in dyskinetic cerebral palsy

B.R. Aravamuthan, J.L. Waugh (Boston, MA, USA)

Pediatric movement disorder · Exhibit Hall located in Hall B, Level 2